298 (PB286): Targeting GPR89 as a novel therapeutic strategy for breast cancer
Ferro, R., Carroll, A., Hickman, O., Vlachogiannis, G., Trendell, J., Krastev, D., Pettitt, S., Amodeo, V., Annunziato, S., Jonkers, J., Liv, N., Pardo, M., Roumeliotis, T.I., Choudhary, J., Natrajan, R., Grigoriadis, A., Madhusudhan, M.S., Haider, S., Lord, C.J., Tutt, A.
Published in European journal of cancer (1990) (01.10.2024)
Published in European journal of cancer (1990) (01.10.2024)
Get full text
Journal Article
The anion channel GPR89 is a novel oncogene associated with tumour specific dependency in breast cancer
Ferro, R., Carroll, A., Mendes-Pereira, A., Reen, V., Roxanis, I., Annunziato, S., Jonkers, J., Liv, N., Alexander, J., Quist, J., Pardo, M., Roumeliotis, T.I., Choudhary, J.S., Weekes, D., Marra, P., Natrajan, R., Grigoriadis, A., Haider, S., Lord, C.J., Tutt, A.J.
Published in European journal of cancer (1990) (01.10.2022)
Published in European journal of cancer (1990) (01.10.2022)
Get full text
Journal Article
CDK/CK1 inhibitors roscovitine and CR8 downregulate amplified MYCN in neuroblastoma cells
Delehouzé, C, Godl, K, Loaëc, N, Bruyère, C, Desban, N, Oumata, N, Galons, H, Roumeliotis, T I, Giannopoulou, E G, Grenet, J, Twitchell, D, Lahti, J, Mouchet, N, Galibert, M-D, Garbis, S D, Meijer, L
Published in Oncogene (11.12.2014)
Published in Oncogene (11.12.2014)
Get full text
Journal Article